You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR CIDOFOVIR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Cidofovir

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000135 ↗ Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed Johns Hopkins Bloomberg School of Public Health Phase 2/Phase 3 1995-09-01 To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis.
NCT00000142 ↗ Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed Baylor College of Medicine Phase 2/Phase 3 1994-04-01 To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗ Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed Icahn School of Medicine at Mount Sinai Phase 2/Phase 3 1994-04-01 To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗ Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed Johns Hopkins University Phase 2/Phase 3 1994-04-01 To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗ Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed Louisiana State University Health Sciences Center in New Orleans Phase 2/Phase 3 1994-04-01 To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗ Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed New Jersey Medical School Phase 2/Phase 3 1994-04-01 To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cidofovir

Condition Name

Condition Name for Cidofovir
Intervention Trials
HIV Infections 15
Cytomegalovirus Retinitis 10
Cytomegalovirus Infections 3
Leukoencephalopathy, Progressive Multifocal 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cidofovir
Intervention Trials
HIV Infections 16
Cytomegalovirus Retinitis 11
Retinitis 11
Infections 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cidofovir

Trials by Country

Trials by Country for Cidofovir
Location Trials
United States 114
France 14
Belgium 8
United Kingdom 7
Australia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cidofovir
Location Trials
California 12
Texas 11
New York 9
Illinois 8
North Carolina 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cidofovir

Clinical Trial Phase

Clinical Trial Phase for Cidofovir
Clinical Trial Phase Trials
Phase 4 4
Phase 3 8
Phase 2/Phase 3 3
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cidofovir
Clinical Trial Phase Trials
Completed 27
Not yet recruiting 5
Unknown status 5
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cidofovir

Sponsor Name

Sponsor Name for Cidofovir
Sponsor Trials
Gilead Sciences 10
National Institute of Allergy and Infectious Diseases (NIAID) 6
Johns Hopkins Bloomberg School of Public Health 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cidofovir
Sponsor Trials
Other 44
Industry 20
NIH 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.